Detailed answers about ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS, including incorporation, status, business activity, and accounts information.
When was ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS founded?
ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS was officially incorporated on 25 August 2009 and is registered under company number 07000073. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS?
PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption). This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS?
ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS do?
ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS operates in the following sector: 88990 - Other social work activities without accommodation n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS's registered address?
The registered office address of ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS is 39 COLEHERNE COURT, THE LITTLE BOLTONS, LONDON, ENGLAND, SW5 0DN. This is the official address filed with Companies House for legal and statutory correspondence.
Is ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS financially stable?
The most recent accounts for ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS were made up to 31 August 2024, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 May 2026.